Dr Reddy's Laboratories Analyst Ratings
BofA Securities Maintains Dr Reddy's Laboratories Ltd(RDY.US) With Buy Rating
Barclays: Maintaining the Dr. Reddy's Laboratories (RDY.US) rating, adjusted from an increase to an increase rating, and the target price was adjusted from $80.00 to $81.00.
Dr Reddy's Laboratories Analyst Ratings
Barclays Maintains Overweight on Dr Reddy's Laboratories, Raises Price Target to $81
Dr Reddy's Laboratories Analyst Ratings
Barclays Adjusts Price Target on Dr. Reddy's Laboratories to $70 From $67, Maintains Overweight Rating
Barclays Adjusts Price Target on Dr. Reddy's Laboratories to $66 From $69, Reiterates Overweight Rating